↓ Skip to main content

Purinergic signalling: past, present and future

Overview of attention for article published in Brazilian Journal of Medical and Biological Research, October 2008

Readers on

mendeley
202 Mendeley
citeulike
3 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Purinergic signalling: past, present and future
Published in
Brazilian Journal of Medical and Biological Research, October 2008
DOI 10.1590/s0100-879x2008005000037
Pubmed ID
Authors
Abstract

The discovery of non-adrenergic, non-cholinergic neurotransmission in the gut and bladder in the early 1960's is described as well as the identification of adenosine 5'-triphosphate (ATP) as a transmitter in these nerves in the early 1970's. The concept of purinergic cotransmission was formulated in 1976 and it is now recognized that ATP is a cotransmitter in all nerves in the peripheral and central nervous systems. Two families of receptors to purines were recognized in 1978, P1 (adenosine) receptors and P2 receptors sensitive to ATP and adenosine diphosphate (ADP). Cloning of these receptors in the early 1990's was a turning point in the acceptance of the purinergic signalling hypothesis and there are currently 4 subtypes of P1 receptors, 7 subtypes of P2X ion channel receptors and 8 subtypes of G protein-coupled receptors. Both short-term purinergic signalling in neurotransmission, neuromodulation and neurosecretion and long-term (trophic) purinergic signalling of cell proliferation, differentiation, motility, death in development and regeneration are recognized. There is now much known about the mechanisms underlying ATP release and extracellular breakdown by ecto-nucleotidases. The recent emphasis on purinergic neuropathology is discussed, including changes in purinergic cotransmission in development and ageing and in bladder diseases and hypertension. The involvement of neuron-glial cell interactions in various diseases of the central nervous system, including neuropathic pain, trauma and ischemia, neurodegenerative diseases, neuropsychiatric disorders and epilepsy are also considered.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 202 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Brazil 2 <1%
Portugal 1 <1%
Italy 1 <1%
Germany 1 <1%
China 1 <1%
Chile 1 <1%
Belgium 1 <1%
Unknown 194 96%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 43 21%
Researcher 30 15%
Student > Master 29 14%
Student > Doctoral Student 21 10%
Student > Bachelor 20 10%
Other 27 13%
Unknown 32 16%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 60 30%
Biochemistry, Genetics and Molecular Biology 30 15%
Medicine and Dentistry 27 13%
Immunology and Microbiology 9 4%
Chemistry 9 4%
Other 29 14%
Unknown 38 19%